Evidence map›Paper›PMID 30003291›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2018

Epigenetic regulation of Toll-like receptors and its roles in type 1 diabetes.

Zhiguo Xie, Gan Huang, Zhen Wang, Shuoming Luo, Peilin Zheng, Zhiguang Zhou

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. rs3806265 and rs4612666 of theFrontiers in endocrinology · 2022
    Article
  6. Frontiers in immunology · 2022
    Review
  7. Innate immunity in latent autoimmune diabetes in adults.Diabetes/metabolism research and reviews · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Role of Tet2 in Regulating Adaptive and Innate Immunity.Frontiers in cell and developmental biology · 2021
    Review
  12. Article
  13. Polymorphisms of theDiabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhiguo XieDepartment of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Gan HuangDepartment of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Zhen WangDepartment of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Shuoming LuoDepartment of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Peilin ZhengDepartment of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Zhiguang ZhouDepartment of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. zhouzhiguang@csu.edu.cn.
Central South University · CNSecond Xiangya Hospital of Central South University · CN

Funding

The National Key Research and Development Program of China 2016YFC1305000The National key technology R&D program 2015BAI12B13The National Natural Science Foundation of China 81400783The strategic forerunner project of Central South University ZLXD2016003
6 · The paper itself

Abstract

The immune system can be divided into adaptive immunity and innate immunity. Adaptive immunity has been confirmed to be involved in the pathogenesis of autoimmune diseases, including type 1 diabetes (T1D). However, the role of innate immunity in T1D has only been studied recently. T1D is caused by selective autoimmune destruction of pancreatic islet β cells. A series of studies have suggested that TLRs play a critical role in the pathogenesis of T1D. Aberrant TLR signaling will change immune homeostasis and result in immunopathological conditions such as endotoxin shock and autoimmune responses. Thus, TLR signaling pathways are supposed to be strictly and finely regulated. Epigenetics has recently been proven to be a new regulator of TLR expression. DNA methylation, histone modification, and microRNAs are the three main epigenetic modifications. This review will mainly focus on these epigenetic mechanisms of regulation of TLRs and the role of TLRs in the pathogenesis of T1D.

Indexed as

Disease SusceptibilityEpigenesis, GeneticGene Expression RegulationAnimalsBiomarkersDiabetes Mellitus, Type 1Disease Models, AnimalDNA MethylationHistonesHumansMicroRNAsSignal TransductionToll-Like ReceptorsBiomarkersHistonesMicroRNAsToll-Like ReceptorsDNA methylationEpigeneticsMicroRNAToll-like receptorType 1 diabetes

Identifiers

PMID30003291
OpenAlexW2881685221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.